154 related articles for article (PubMed ID: 14132176)
1. COMPARISON OF CYCLOPHOSPHAMIDE (CYTOXAN AND URACIL MUSTARD (U-8344) IN CHRONIC GRANULOCYTIC LEUKEMIA.
FROMMEYER WB
Cancer; 1964 Mar; 17():288-96. PubMed ID: 14132176
[No Abstract] [Full Text] [Related]
2. [COMBINED TREATMENT OF CHRONIC MYELOCYTIC LEUKEMIA].
SPASSKII OV
Sov Med; 1963 Dec; 27():9-14. PubMed ID: 14150370
[No Abstract] [Full Text] [Related]
3. MULTIVARIATE COMPARISON OF RESULTS OF TREATMENT IN CHRONIC LYMPHOCYTIC AND CHRONIC GRANULOCYTIC LEUKEMIA.
GRIZZLE JE
J Chronic Dis; 1964 Feb; 17():127-52. PubMed ID: 14123832
[No Abstract] [Full Text] [Related]
4. ANTI-LEUKAEMIC DRUGS.
INNES J
Practitioner; 1964 Jul; 193():101-6. PubMed ID: 14194581
[No Abstract] [Full Text] [Related]
5. CHRONIC LEUKEMIA.
MOLANDER DW; LADUE JS
Geriatrics; 1964 Jun; 19():393-406. PubMed ID: 14169095
[No Abstract] [Full Text] [Related]
6. STEROID HORMONE METABOLISM IN CHRONIC MYELOGENOUS LEUKEMIA.
GALLAGHER TF; HELLMAN L; ZUMOFF B; MILLER DG
Blood; 1965 May; 25():743-8. PubMed ID: 14282043
[No Abstract] [Full Text] [Related]
7. [PRESENT STATUS OF LEUKEMIA CHEMOTHERAPY].
BOUSSER J
Rev Prat; 1963 Dec; 13():SUPPL 113-7. PubMed ID: 14099268
[No Abstract] [Full Text] [Related]
8. DIHYDROXYBUSULFAN (NSC-39069) IN CHRONIC MYELOCYTIC LEUKEMIA AND MISCELLANEOUS MALIGNANT NEOPLASMS.
LOEB V
Cancer Chemother Rep; 1964 Nov; 42():39-43. PubMed ID: 14226129
[No Abstract] [Full Text] [Related]
9. THE LOCAL INFLAMMATORY RESPONSE IN PATIENTS WITH BLOOD DYSCRASIAS AS TESTED BY THE SKIN WINDOW TECHNIQUE.
WEBER RE; HELMAN N
Bull Sinai Hosp Detroit; 1963; 11():95-9. PubMed ID: 14064458
[No Abstract] [Full Text] [Related]
10. OLD AND NEW DRUGS IN THE CONTROL OF CHRONIC GRANULOCYTIC LEUKEMIA.
SAMPEY JR
Am J Pharm Sci Support Public Health; 1964; 136():165-74. PubMed ID: 14203736
[No Abstract] [Full Text] [Related]
11. EXPERIMENTAL STUDY OF OLIVOMYCIN, AN ANTITUMOUR ANTIBIOTIC.
CHORIN VA; ROSSOLIMO OK; GOLDBERG LE; STANISLAVSKAYA MS; BLUMBERG NA; VERTOGRADOVA TP
Acta Unio Int Contra Cancrum; 1964; 20():289-90. PubMed ID: 14151910
[No Abstract] [Full Text] [Related]
12. SEVERAL CELL-LINES WITH ABNORMAL KARYOTYPES IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKAEMIA.
PEDERSEN B; VIDEBAEK A
Scand J Haematol; 1964; 1():129-37. PubMed ID: 14184546
[No Abstract] [Full Text] [Related]
13. CLINICAL EVALUATION OF URACIL MUSTARD.
WILLIAMS HM
Cancer Chemother Rep; 1963 Oct; 32():73-6. PubMed ID: 14088838
[No Abstract] [Full Text] [Related]
14. CLOSED PELVIC PERFUSION IN ADVANCED GYNECOLOGIC CANCER.
CAVANAGH D; MARTIN DS; FERGUSON JH
South Med J; 1965 May; 58():549-57. PubMed ID: 14280772
[No Abstract] [Full Text] [Related]
15. Treatment of leukaemias and reticuloses with uracil mustard.
WILKINSON JF; BOURNE MS; ISRAELS MC
Br Med J; 1963 Jun; 1(5345):1563-8. PubMed ID: 14000759
[No Abstract] [Full Text] [Related]
16. Effect of my-leran and 6-mercaptopurine (6-MP) on the serum level of vitamin B12 in chronic myelocytic leukemia.
DOCTOR VM; BERGSAGEL DE; SHULLENBERGER CC
Blood; 1959 Mar; 14(3):274-8. PubMed ID: 13628825
[No Abstract] [Full Text] [Related]
17. [MELANODERMA IN THE COURSE OF TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH MYLERAN].
LINQUETTE M; MESMACQUE R; FOSSATI P; GASNAULT JP
Lille Med; 1965 Mar; 10():289-91. PubMed ID: 14317074
[No Abstract] [Full Text] [Related]
18. Evaluation of the comparative effectiveness of Myleran and 6-MP in the management of patients with chronic myelocytic leukemia.
SHULLENBERGER CC
Cancer Chemother Rep; 1962 Feb; 16():203-7. PubMed ID: 13912386
[No Abstract] [Full Text] [Related]
19. CHEMOTHERAPY OF ACUTE LEUKEMIA.
FREI E
CA Cancer J Clin; 1964; 14():252-6. PubMed ID: 14216115
[No Abstract] [Full Text] [Related]
20. Effect of uracil mustard in malignant lymphoma and chronic lymphatic leukemia.
THEOLOGIDES A; KENNEDY BJ
Minn Med; 1962 Feb; 45():165-8. PubMed ID: 13920550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
